UCPH Health Science News (2018.09.26)

Professor Hans Wandall from Copenhagen Center for Glycomics was interviewed by the UCPH Health News about the publication "Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen specific T-cell reactivity" which was recently published in the Journal of Allergy and Clinical Immunology".

Mathiesen CBK, Carlsson MC, Brand S, Möller SR, Idorn M, Straten PT, Pedersen AE, Dabelsteen S, Halim A, Würtzen PA, Brimnes J, Ipsen H, Petersen BL, Wandall HH (2018): Genetically engineered cell factories produce glycoengineered vaccines that target antigen presenting cells and reduce antigen specific T-cell reactivity. J Allergy Clin Immunol Aug 17. DOI: 10.1016/j.jaci.2018.07.030 (Epub ahead of print)